Skip to main content
. 2024 Jan 10;12(4):2294–2310. doi: 10.1002/fsn3.3959

TABLE 1.

Various clinical studies supporting the therapeutic potential of fenugreek seeds.

Supplement Study type Subject Treatment Outcomes Reference
Fenugreek seed powder Double‐blind, randomized controlled clinical trial (RCT) 60 patients‐mechanically ventilated 3 mg twice daily for 5 days Reduces gastrointestinal (GI) bleeding, bloating, and heartburn Zarghi et al. (2021)
Fenugreek seed extract Randomized exploratory study 54 patients 500 mg/day for 12 weeks Improves blood glucose metabolism Pickering et al. (2022)
Gel from fenugreek seed A double‐blind placebo‐controlled clinical trial 60 patients with trichoptilosis 500 μg/mL for 2 months Herbal gel from fenugreek seed reduces the incidence of hair loss and trichoptilosis Hajizadeh et al. (2022)
Fenugreek seed extract (metformin and the hydroalcoholic) Mice study 52 diabetics induced Wistar rats 50 mg/kg, 100 mg/kg, and 200 mg/kg of the extract for 48 h Reduces oxidative damage in brain and reduces memory loss resulting from diabetes Bafadam et al. (2019)
Metformin‐fenugreek seed extract Mice study 42 diabetics induced male rats 50 mg/kg, 100 mg/kg, and 200 mg/kg, 300 mg/kg of the extract for 6 weeks Reduces oxidative stress, improves metabolism, and reduces apoptosis Bafadam et al. (2021)
Fenugreek seed extract Clinical trial 100 healthy males aged 45–80 years 600 mg/day for 12 weeks No change observed in benign prostate hyperplasia Rao and Grant (2020)
Fenugreek seed extract in capsule A double‐blind, randomized placebo‐controlled clinical trial 58 oligo‐anovulatory polycystic ovary syndrome (PCOS) women 1 capsule for 8 weeks PCOS improved in women Bashtian et al. (2013)